Nuclear Magnetic Resonance Spectroscopy of Cancer
- 1 November 1997
- journal article
- review article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 70 (Special--1) , S60-S69
- https://doi.org/10.1259/bjr.1997.0009
Abstract
Nuclear magnetic resonance spectroscopy (MRS) offers a non-invasive approach for studying tumour biochemistry and physiology. This review highlights NMR nuclei (31P, 1H, 19F, 13C, 2H) that have been observed in both pre-clinical and clinical spectroscopic studies of cancerKeywords
This publication has 72 references indexed in Scilit:
- Effects of blood flow modifiers on tumor metabolism observedin vivoby proton magnetic resonance spectroscopic imagingMagnetic Resonance in Medicine, 1996
- 1H MR Spectroscopy in Patients with Metastatic Brain Tumors: A Multicenter StudyMagnetic Resonance in Medicine, 1995
- Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumoursNMR in Biomedicine, 1995
- 6‐Fluoropyridoxol: A novel probe of cellular pH using 19F NMR spectroscopyFEBS Letters, 1994
- In vivo19F NMR studies of hyperthermia: Hydrophobic environments probed by halothaneNMR in Biomedicine, 1993
- A new perfluorocarbon for use in fluorine‐19 magnetic resonance imaging and spectroscopyMagnetic Resonance in Medicine, 1993
- In vivo and ex vivo magnetic resonance spectroscopy as applied to pharmacokinetic studies with anticancer agents: a reviewNMR in Biomedicine, 1992
- Hepatic intracellular pH in Vivo using F‐quene 1 and 19F NMR spectroscopyMagnetic Resonance in Medicine, 1991
- Relative volume‐average murine tumor blood flow measurement via deuterium nuclear magnetic resonance spectroscopyMagnetic Resonance in Medicine, 1991